Search research articles
Contact Us
Filters
Showing results (101-110 of 113) with videos related to
Page
of 12
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2011
NCCN Clinical Practice Guidelines Occult primary
David S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2019
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer
Jorge Blando, Anu Sharma, Maria Gisela Higa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2008
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
Gauri R Varadhachary, Robert A Wolff, Christopher H Crane, et al.
JAMA Surgery
|
July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma
Jordan M Cloyd, Huamin Wang, Michael E Egger, et al.
JCO Precision Oncology
|
September 11, 2020
Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer
Eugene J Koay, Matthew H G Katz, Huamin Wang, et al.
Cancer
|
November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies
Minny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
The Journal of Clinical Investigation
|
March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and response
Eugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 5, 2014
Occult primary, version 3.2014
David S Ettinger, Charles R Handorf, Mark Agulnik, et al.
Physical Biology
|
November 27, 2014
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer
Eugene J Koay, Flavio E Baio, Alexander Ondari, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 26, 2016
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience
Jordan M Cloyd, Matthew H G Katz, Laura Prakash, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 113) with videos related to
Sort By:
Page
of 12
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 14, 2011
NCCN Clinical Practice Guidelines Occult primary
David S Ettinger, Mark Agulnik, Justin M M Cates, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2019
Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer
Jorge Blando, Anu Sharma, Maria Gisela Higa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2008
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
Gauri R Varadhachary, Robert A Wolff, Christopher H Crane, et al.
JAMA Surgery
|
July 13, 2017
Association of Clinical Factors With a Major Pathologic Response Following Preoperative Therapy for Pancreatic Ductal Adenocarcinoma
Jordan M Cloyd, Huamin Wang, Michael E Egger, et al.
JCO Precision Oncology
|
September 11, 2020
Computed Tomography-Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer
Eugene J Koay, Matthew H G Katz, Huamin Wang, et al.
Cancer
|
November 2, 2018
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies
Minny Bhatty, Shumei Kato, Sarina A Piha-Paul, et al.
The Journal of Clinical Investigation
|
March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and response
Eugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 5, 2014
Occult primary, version 3.2014
David S Ettinger, Charles R Handorf, Mark Agulnik, et al.
Physical Biology
|
November 27, 2014
Intra-tumoral heterogeneity of gemcitabine delivery and mass transport in human pancreatic cancer
Eugene J Koay, Flavio E Baio, Alexander Ondari, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 26, 2016
Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience
Jordan M Cloyd, Matthew H G Katz, Laura Prakash, et al.
Page
of 12